Menotropin biosimilar (Klarvoyant Biogenics)

尿促性素生物类似药 (Klarvoyant Biogenics)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMenotropin biosimilar (Klarvoyant Biogenics)
Drug Alias Name尿促性素生物仿制药 (Klarvoyant Biogenics)Gamigro-M
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor modulatorsLuteinizing hormone/Choriogonadotropin receptor modulators
TargetsFollicle-stimulating hormone receptorLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsInfertility
Global Approved IndicationsInfertility
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2013/07/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesInfogix
China Registration ClassN/A

Develop Information

Active CompaniesInfogix
Inactive CompaniesN/A
Active IndicationsInfertility
Inactive IndicationsN/A

Other Information

ATC CodeG03GA04
Related LinksN/A